A week that began with the sharpest pullback in equities since last fall concluded in remarkable fashion, as investor concerns about the economic repercussions of rising COVID-19 infections gave way to an increasingly constructive second quarter earnings season.
The Taming of the Flu
This week, “all the world’s a stage,” especially for William Shakespeare, the second person to be inoculated with the Pfizer vaccine in the UK. In the U.S., an outside panel of independent experts recommended Pfizer’s vaccine approval for emergency authorization. And as indicated this morning, FDA emergency use authorization approval should come shortly.
Two Steps Forward, One Step Back
Economic data the past week reinforced the view that the U.S. economy continues to improve. This was highlighted by the retail sales number released by the U.S. Department of Commerce on Thursday morning.
And Yet It Moves …
There were a number of moving pictures this past week that we could cover. One topic that we have not covered in our communication that caught our attention this week is … opioids.